Does NICARDIPINE Cause Injection site extravasation? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Injection site extravasation have been filed in association with NICARDIPINE (NICARDIPINE HYDROCHLORIDE). This represents 0.4% of all adverse event reports for NICARDIPINE.
8
Reports of Injection site extravasation with NICARDIPINE
0.4%
of all NICARDIPINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Injection site extravasation From NICARDIPINE?
Of the 8 reports, 4 (50.0%) required hospitalization.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NICARDIPINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does NICARDIPINE Cause?
Foetal exposure during pregnancy (214)
Premature baby (192)
Hypotension (173)
Maternal exposure during pregnancy (162)
Acute kidney injury (154)
Drug ineffective (125)
Fall (115)
Low birth weight baby (103)
Premature delivery (100)
Exposure during pregnancy (91)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which NICARDIPINE Alternatives Have Lower Injection site extravasation Risk?
NICARDIPINE vs NICORANDIL
NICARDIPINE vs NICORETTE OTC
NICARDIPINE vs NICORETTE OTC, UNSPECIFIED
NICARDIPINE vs NICOTINE
NICARDIPINE vs NIFEDIPINE